AbbVie Discontinues Phase III Trial of Drug to Treat Small-Cell Lung Cancer - TheStreet.com

AbbVie Discontinues Phase III Trial of Drug to Treat Small-Cell Lung Cancer  TheStreet.com

Shares of AbbVie (ABBV - Get Report) were rising as the company said it would discontinue a Phase III trial of its Rova-T treatment for advanced small-cell lung ...



Comments

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Stage 4 Lung Cancer Life Expectancy

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...